Abide Therapeutics Appoints Thomas C. Südhof to Board of Directors

SAN DIEGO, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes with an emphasis on CNS disorder... Biopharmaceuticals, Personnel Abide Therapeutics, serine hydrolase
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news